Literature DB >> 9205894

Ruthenium-106 eye plaque brachytherapy in the conservative treatment of uveal melanoma: evaluation of 175 patients treated with 150 Gy from 1981-1989.

R Pötter1, K Janssen, F J Prott, J Widder, U Haverkamp, H Busse, R P Müller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9205894     DOI： 10.1159/000425697

Source DB:  PubMed          Journal:  Front Radiat Ther Oncol        ISSN： 0071-9676


× No keyword cloud information.
  3 in total

1.  [High-dose 106Ruthenium plaque brachytherapy for posterior uveal melanoma. A clinico-pathologic study].

Authors:  L M Heindl; M Lotter; V Strnad; R Sauer; G O H Naumann; H L J Knorr
Journal:  Ophthalmologe       Date:  2007-02       Impact factor: 1.059

2.  Ruthenium-106 Brachytherapy with or without Additional Local Therapy Shows Favorable Outcome for Variable-Sized Choroidal Melanomas in Korean Patients.

Authors:  Yeona Cho; Jee Suk Chang; Jin Sook Yoon; Sung Chul Lee; Yong Bae Kim; Joo Ho Kim; Ki Chang Keum
Journal:  Cancer Res Treat       Date:  2017-03-24       Impact factor: 4.679

3.  Triamcinolone acetonide and anecortave acetate do not stimulate uveal melanoma cell growth.

Authors:  Mariam El Filali; Irene Homminga; Willem Maat; Pieter A van der Velden; Martine J Jager
Journal:  Mol Vis       Date:  2008-09-24       Impact factor: 2.367
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.